BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 30, 2020
View Archived Issues
GT Biopharma advances new TriKE therapy for breast and gastrointestinal cancers
Read More
Intra-Cellular initiates clinical programs for ITI-LLAI and ITI-333
Read More
MATR3 S85C knock-in mice mimic behavioral and neuropathological features of human early-stage ALS
Read More
RCAN1 is involved in tubulointerstitial fibrosis progression by regulating mitochondrial quality
Read More
Novel lipid conjugates of APJ agonist peptides show prolonged half-life for once-daily dosing
Read More
YF17D-based COVID-19 vaccine candidate induces protective immunity within 10 days with a single dose
Read More
Max-Delbrueck-Centrum fuer Molekulare Medizin, DZNE patent chimeric autoantibody receptors
Read More
New mutant LRRK2 inhibitors identified at Merck & Co.
Read More
Compounds for treating rabies patented by Oita University Institute of Advanced Medicine
Read More
BIAL-Portela & Ca. discovers dopamine beta-monooxygenase inhibitors
Read More
3M Pharmaceuticals presents new TLR7/8 agonists
Read More
Phase IIb/III trial of Zyesami for respiratory failure in critical COVID-19 completes enrollment
Read More
Hepion reports topline low-dose data from phase IIa trial of CRV-431 in NASH
Read More
Vaxil offers update on COVID-19 vaccine research
Read More
FDA issues complete response letter for Osmotica's arbaclofen ER for MS spasticity
Read More
NUSAP1 linked to poor prognosis in chronic lymphocytic leukemia
Read More
U.K. MHRA authorizes AstraZeneca's COVID-19 vaccine for emergency supply
Read More
New clinical program studies Emergent's COVID-HIG product candidate for COVID-19 prophylaxis
Read More
COVID anniversary coincides with more transmissible strains
Read More
Final results from phase III BRIDGE study of pegunigalsidase alfa for Fabry disease
Read More
Opdivo SCLC indication withdrawn in U.S.
Read More
Polish authorities grant new indication for Dexaven to treat COVID-19
Read More
